Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Nippon Chemiphar Co. Ltd.
DescriptionXanthine oxidoredcutase inhibitor
Molecular Target Xanthine oxidase ; Uric acid
Mechanism of ActionXanthine oxidase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHyperuricemia / gout
Indication DetailsTreat hyperuricemia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today